New and Improved Version of ReSSQ® CMV and EBV Assays for European Distribution
LightUp Technologies AB and DakoCytomation A/S now have available further improved versions of LightUp Technologies' already established ReSSQ® CMV and EBV Assays for the monitoring of cytomegalovirus (CMV) and Epstein-Barr virus (EBV) in clinical specimens.
The new versions feature a range of improvements giving highly accurate and reproducible sample testing and ease of use for the laboratory. The ReSSQ Assays have been demonstrated to be very robust and sensitive, and are validated for use in conjunction with several real-time PCR instrument platforms.
In 2004 DakoCytomation and LightUp Technologies entered into a distribution agreement for LightUp Technologies' infectious disease diagnostic tests based on nucleic acid detection. The agreement grants DakoCytomation co-exclusive rights to market and sell LightUp's products in Europe.
Source: LightUp Technologies AB View archived contact details
Posted: July 29, 2005
[will open your email client]